Incorporation of wholly owned foreign subsidiary Triton Farmaceutica do Brasil Ltda in Brazil
Granules India has incorporated a wholly owned foreign subsidiary, Triton Farmaceutica do Brasil Ltda, in Brazil.
- Subsidiary Name
- Triton Farmaceutica do Brasil Ltda
- Country
- Brazil
- Subsidiary Status
- wholly owned foreign subsidiary; has not started business
- Purpose
- manufacture, promote, sale and distribute pharmaceuticals there
- Promoter Interest
- Promoter and Promoter Group hold no interest in it
Granules India has informed the stock exchanges that it has incorporated a wholly owned foreign subsidiary in Brazil.
The entity that was incorporated
- Name: TRITON FARMACEUTICA DO BRASIL LTDA
- Country: Brazil
- Status: newly incorporated, and it has not started its business
- Industry: Pharmaceuticals
- Purpose: to manufacture, promote, sale and distribute pharmaceuticals and other related product(s) in Brazil
Ownership and related party position
- The entity is a wholly owned subsidiary of the company
- Upon incorporation, it became a related party of the company
- The Promoter and Promoter Group of the company do not have any interest in the entity incorporated
Approval needed
- Prior approval of the Reserve Bank of India (RBI) under the automatic route
Other points listed in the disclosure
- The company has stated Not Applicable against the indicative time period for completion of the acquisition, the nature of consideration, and the cost of acquisition or the price at which shares are acquired
What this means for a retail investor
- A wholly owned subsidiary means the Brazil entity is fully owned by the company, with no outside partner sharing ownership in it.
- This is a corporate structure step: the entity is at incorporation stage and has not started its business.
- The stated object is to manufacture, promote, sell and distribute pharmaceuticals in Brazil, which points to building a presence in that market.
- The information is a company intimation about setting up a new overseas entity, not a financial result or an order.
In short, the company has incorporated a wholly owned subsidiary in Brazil for a pharmaceuticals business there, and the Promoter and Promoter Group hold no interest in the new entity.
Also from Granules India
Paragraph IV certification submitted for Ruxolitinib Extended-Release Tablets ANDA; potential first-to-file eligibility
7 Oct 2026
Webinar transcript: four growth engines, two sole first-to-file ANDAs, complex generics at 33% of FY26 revenue
6 Oct 2026
Audio recording of September 29, 2026 webinar uploaded on Granules India website
29 Sep 2026
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.